Home › Funds › Arrowstreet Capital › BVS
Arrowstreet Capital position in BVS
BIOVENTUS INC · Health Care
Latest position (Q2 2026)158.69K sh
Reported value held$1.50M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 102.94K | $1.46M | New |
| Q4 2021 | 341.51K | $4.95M | Add |
| Q1 2022 | 87.95K | $1.24M | Reduce |
| Q2 2026 | 158.69K | $1.50M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BVS
- BlackRock Inc 3.44M sh · $32.44M · Q2 2026
- Vanguard Group 2.98M sh · $22.21M · Q4 2025
- Royce & Associates 1.83M sh · $17.31M · Q2 2026
- Geode Capital Management 1.37M sh · $12.89M · Q2 2026
- Wellington Management Group 748.36K sh · $7.06M · Q2 2026
- Renaissance Technologies 736.00K sh · $6.95M · Q2 2026
- Goldman Sachs Group 652.37K sh · $6.16M · Q2 2026
- Fidelity Management & Research (FMR) 452.85K sh · $4.27M · Q2 2026
- Northern Trust Corp 443.82K sh · $4.19M · Q2 2026
- Prudential Financial 394.52K sh · $3.72M · Q2 2026
- Charles Schwab Investment Management 391.86K sh · $3.70M · Q2 2026
- AQR Capital Management 326.12K sh · $3.08M · Q2 2026